Free Shipping Orders >$250
✓ FREE & Private Global Delivery ›
✓ We Dispatch The Freshest Batch
✓ Discreet Shipping Within 24h Daily
✓ 100% Original Products Guaranteed
✓ Great Customer Service
✓ Competitive prices on all products
✓ Only Secure Card Payment Methods ›
✓ Our genuinely Earned Reputation ›
✓ Buy more - Save more ›

Suviray® Erenumab Injection

Erenumab 70mg/ml

USD $720.00


Erenumab injection is used to prevent migraine headaches. Suviray Injection is a human monoclonal antibody. It works by binding to the calcitonin gene-related peptide (CGRP) receptor and antagonizes CGRP receptor function.

Size: 1 Pre-Filled Syringe 1ml/0.03fl.oz
Brand name: Aimovig
Title Range Discount
Items: 2 - 4 5%
Items: 5 - 8 10%
Items: 9 + 15%


What is Suviray® Erenumab Injection?

A migraine is usually a moderate or severe headache felt as a throbbing pain on 1 side of the head. Many people also have symptoms such as feeling sick, being sick, and increased sensitivity to light or sound. Migraine is a common health condition, affecting around 1 in every 5 women and around 1 in every 15 men.

Erenumab (brand name Aimovig) is a medication used for the preventative treatment of migraines in adults. It is a type of medication known as a calcitonin gene-related peptide (CGRP) receptor antagonist. CGRP is a protein that is involved in the transmission of pain signals in the brain, and blocking its activity can help reduce the frequency and severity of migraines.

Erenumab is administered as a subcutaneous injection once a month, and it works by binding to the CGRP receptor and preventing CGRP from activating it. It was approved by the US Food and Drug Administration (FDA) in 2018 and has since been approved in many other countries for the treatment of migraines.

As with all medications, Erenumab can have side effects, which can include injection site reactions, constipation, and muscle spasms. It is important to discuss the potential benefits and risks of Erenumab with your healthcare provider to determine if it is the right treatment option for you.

Suviray Injection is a calcitonin gene-related peptide receptor antagonist. It is used in the preventive treatment of migraine in adults. It works by blocking the receptors for the protein CGRP, thought to play a major role in starting migraines.

Suviray Injection is given as an injection in the abdomen, thigh, or upper arm subcutaneously. Before administering the injection, allow the medicine to be at room temperature for at least 30 minutes protected from direct sunlight. Do not warm by using a heat source such as hot water or a microwave. Do not inject the medicine into areas where the skin is tender, bruised, or hard.

The most common side effects of this medicine are injection site reactions (such as pain, swelling, and redness) and constipation. It may also cause itching and muscle spasms in some people. If you experience such side effects that do not heal on their own or get worse, inform your doctor. They may be able to help you reduce or treat the side effects.

Do not use Suviray Injection if you are allergic to Erenumab or any ingredients of the medicine. Before using the doctor about all your medical conditions. To make sure it is safe for you, let your doctor also know if you are pregnant, planning to become pregnant, or breastfeeding.

In Prevention of Migraine. Suviray Injection blocks the action of a certain natural substance in the body that causes migraine headaches. This prevents migraines. Preventing and reducing the frequency of migraine headaches can help you carry out your daily activities and have a better quality of life.

Additional Information


There are no reviews yet.

Be the first to review “Suviray® Erenumab Injection”

Your email address will not be published. Required fields are marked *